Debut Bio News Today

INX International Ink has completed an investment in Debut, a vertically integrated synthetic biology company. Debut is developing innovative and complex active ingredients for natural colors among other materials.

INX International Invests in Debut Bio to Accelerate Development of Sustainable Inks Via Biomanufacturing

Debut Biotech teams up with DIC to explore novel, ‘cell-free’ approach to biomanufacturing natural food colors Fine chemicals co DIC has teamed up with San Diego-based startup Debut Biotech to develop color ingredients via a novel ‘cell-free’ biomanufacturing platform, which it claims could enable the biosynthesis of colors that are “hard to find or even inaccessible in nature.” The first food colors were made from plants, but were gradually replaced by p...

Ingredients giant DSM has teamed up with San Diego-based startup Debut Biotech to explore the potential of its ‘cell-free’ biomanufacturing platform, a next-generation manufacturing process it claims could unlock new opportunities to biosynthesize a far wider set of natural ingredients, transforming low-value bio-renewable materials into high-value specialty ingredients. The agreement will enable a proof of concept opportunity for Debut Biotech’s cell-free plat...